Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
WindMIL Therapeutics and University of California, Irvine Announce Collaboration to Collect Bone Marrow from Patients with Gliomas
Wednesday, October 16, 2019WindMIL Therapeutics and the University of California Irvine UCI today announced that the first patients have been identified in an investigatorsponsored study for the collection of bone marrow from patients with gliomas The study will evaluate gener...
PharmaCyte Biotech Successfully Completes Manufacturing of Clinical Trial Product
Tuesday, October 15, 2019PharmaCyte Biotech Inc a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature livecell encapsulation technology CellinaBox announced today that its partner Austrianova Singapore Austrianova has co...
Novigenix and RadioMedix to Develop Neuroendocrine Cancer Precision Diagnostic Test
Tuesday, October 15, 2019Novigenix SA a leading ImmunoTranscriptomics company that develops and commercializes solutions for early cancer detection and precision medicine today announced a collaboration agreement with RadioMedix Inc a radiopharmaceutical company to develop a...
Shionogi enters into a new license agreement and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics, Inc.
Monday, October 14, 2019Shionogi Co Ltd today announced that it has entered into a new license agreement with Hsiri Therapeutics Inc Head Office Media PA USA President and CEO William Claypool MD hereafter Hsiri regarding a collaborative research and development program to...
Neumentum Enters into Global Licensing Agreement for a Novel Class of Investigational Pain Treatments
Friday, October 11, 2019Neumentum Inc a pharmaceutical company dedicated to transforming the way pain is treated today announced it has entered into a global licensing agreement with Janssen Pharmaceutica NV and McNeil Consumer Pharmaceuticals Co both part of the Johnson J...
Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research
Friday, October 11, 2019Advaxis Inc a clinicalstage biotechnology company focused on the discovery development and commercialization of immunotherapy products today announced a research collaboration agreement with the University of California Los Angeles UCLA to conduct pr...
Viela Bio Enters Strategic Collaboration with Mitsubishi Tanabe Pharma to Develop and Commercialize Inebilizumab for Autoimmune Diseases in Japan and Other Asia Regions
Thursday, October 10, 2019Viela Bio Inc and Mitsubishi Tanabe Pharma Corporation MTPC today announced a collaboration focused on the development and commercialization of inebilizumab Vielas humanized antiCD monoclonal antibody in nine Asia regions for neuromyelitis optica s...
CORRECTING and REPLACING VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences
Thursday, October 10, 2019VirTrial has been awarded an FDAapproved hybrid decentralized clinical trial DCT with Hope Biosciences The study provides Hope Biosciences autologous adiposederived cultureexpanded mesenchymal stem cells HBadMSCs for the treatment of spinal cord inju...
4D Pharma collabor4D Pharma collaborates with MSD to develop live biotherapeutic products for vaccinesates with MSD to develop live biotherapeutic products for vaccines
Wednesday, October 09, 2019D pharma plc a leading pharmaceutical company in the development of live biotherapeutics today announces that the company has entered into a research collaboration agreement and an option license to use with MSD trading name of Merck Co Inc in Kenil...
Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases
Wednesday, October 09, 2019Prevail Therapeutics Inc a biotechnology company developing potentially diseasemodifying AAVbased gene therapies for patients with neurodegenerative disorders and Lonza today announced that the companies have entered into a strategic collaboration
